Tuberculosis research symposium hosted at the Centenary Institute

Tuberculosis remains the world’s deadliest infectious disease, claiming approximately 1.3 million lives each year. Against this backdrop, the symposium provided a valuable opportunity for attendees to share new findings, build collaborations and advance innovative research aimed at addressing key tuberculosis control challenges.

Centenary researchers featured in the scientific program and included Dr Jeremy Hill who presented on the PEARL study which is investigating community-wide screening and prevention strategies for tuberculosis and leprosy in South Tarawa, Kiribati.

Centenary’s Dr Claudio Counoupas also presented at the symposium, exploring the potential role of mRNA-based vaccines in improving protection against tuberculosis.

The symposium underscored the critical role of collaboration in addressing one of the world’s most significant infectious disease challenges while supporting the development of evidence-based solutions to improve health outcomes in affected communities.

Funded by the National Health and Medical Research Council (NHMRC), the TB-CRE is committed to advancing world-class research to improve the detection, prevention and treatment of TB both in Australia and globally. The Centenary Institute is proud to be an affiliate of the TB-CRE and to support its collaborative research mission.